ArticleOncology letters2017

Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia.

Hong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.